可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Brown RD,Ambler SK,Mitchell MD,et al.The cardiac fibroblast:therapeutic target in myocardial remodeling and failure[J].Annu Rev Pharmacol Toxicol,2005,45:657-687.
[2]Porter KE,Turner NA.Cardiac fibroblasts:at the heart of myocardial remodeling[J].Pharmacol Ther,2009,123(2):255-278.
[3]Iwata M,Cowling RT,Yeo SJ,et al.Targeting the ACE2-Ang-(1-7)pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure[J]. J Mol Cell Cardiol,2011,51(4):542-547.
[4]Banerjee I,Yekkala K,Borg TK,et al.Dynamic interactions between myocytes,fibroblasts, and extracellular matrix[J].Ann N Y Acad Sci,2006,1080:76-84.
[5]Romaine SP,Tomaszewski M,Condorelli G,et al.MicroRNAs in cardiovascular disease:an introduction for clinicians[J].Heart,2015,101(12):921-928.
[6]Lawrie CH.MicroRNAs and lymphomagenesis:a functional review[J].Br J Haematol,2013,160(5):571-581.
[7]Indolfi C,Curcio A.Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy[J].J Clin Invest,2014,124(5):1896-1898.
[8]Liu S,Li W,Xu M,et al.Micro-RNA 21 Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts[J].Can J Cardiol,2014,30(12):1689-1699.
[9]Castoldi G,Di Gioia CR,Bombardi C,et al.MiR-133a regulates collagen 1A1:potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension[J].J Cell physiol,2012,227(2):850-856.
[10]Dostal D,Glaser S,Baudino TA.Cardiac fibroblast physiology and pathology[J].Compr Physiol,2015,5(2):887-909.
[11]Deb A,Ubil E.Cardiac fibroblast in development and wound healing[J].J Mol Cell cardiol,2014,70:47-55.
[12]Roche P,Czubryt MP.Transcriptional control of collagen I gene expression[J].Cardiovasc Hematol Disord Drug Targets,2014,14(2):107-120.
[13]Cao Z,Cooper ME:Efficacy of renin-angiotensin system(RAS)blockers on cardiovascular and renal outcomes in patients with type 2 diabetes[J].Acta Diabetol,2012,49(4):243-254.
[14]Lindsay ME,Dietz HC.Lessons on the pathogenesis of aneurysm from heritable conditions[J].Nature,2011,473(7347):308-316.
[15]McKinney CA,Fattah C,Loughrey CM,et al.Angiotensin-(1-7)and angiotensin-(1-9):function in cardiac and vascular remodelling[J].Clin Sci,2014,126(12):815-827.
[16]Nishida M,Kitajima N,Saiki S,et al.Regulation of Angiotensin II receptor signaling by cysteine modification of NF-kappaB[J].Nitric oxide,2011,25(2):112-117.
[17]Rosenkranz S.TGF-beta1 and angiotensin networking in cardiac remodeling[J].Cardiovasc Res,2004,63(3):423-432.
[18]Thum T,Gross C,Fiedler J,et al.MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts[J].Nature,2008,456(7224):980-984.
[19]Cheng Y,Ji R,Yue J,et al.MicroRNAs are aberrantly expressed in hypertrophic heart:do they play a role in cardiac hypertrophy?[J].Am J Pathol,2007,170(6):1831-1840.
[20]Adam O,Lohfelm B,Thum T,et al.Role of miR-21 in the pathogenesis of atrial fibrosis[J].Basic Res Cardiol,2012,107(5):278.